Martínez-López F, Oñate-Sánchez R, Arrieta-Blanco JJ, Oñate-Cabrerizo D, Cabrerizo-Merino MC. Clinical diseases with thrombotic risk and their pharmacologycal treatment: How they change the therapeutic attitude in dental treatments. Med Oral Patol Oral Cir Bucal. 2013 Nov 1;18 (6):e888-95.

 

 

doi:10.4317/medoral.19561

http://dx.doi.org/doi:10.4317/medoral.19561

 

 

1. Pototski M, Amenábar JM. Dental management of patients receiving anticoagulation or anti-platelet treatment. J Oral Sci. 2007;49:253-8.
http://dx.doi.org/10.2334/josnusd.49.253
PMid:18195506

 

2. Michelson AD. P2Y12 antagonism: promises and challenges. Arterioscler Thromb Vasc Biol. 2008;28:s33-8.
http://dx.doi.org/10.1161/ATVBAHA.107.160689
PMid:18174449

 

3. Fintel DJ. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc Health Risk Manag. 2012;8:77-89.
http://dx.doi.org/10.2147/VHRM.S26030
PMid:22393298 PMCid:PMC3292409

 

4. John J, Koshy SK. Current oral antiplatelets: focus update on prasugrel. J Am Board Fam Med. 2012;25:343-9.
http://dx.doi.org/10.3122/jabfm.2012.03.100270
PMid:22570398

 

5. Lazar LD, Lincoff AM. Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk. Cleve Clin J Med. 2009;76:707-14.
http://dx.doi.org/10.3949/ccjm.76a.09116
PMid:19952295

 

6. Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011;112:292-318.
http://dx.doi.org/10.1213/ANE.0b013e318203f38d
PMid:21212258

 

7. Schafer JA, Kjesbo NK, Gleason PP. Critical review of prasugrel for formulary decision makers. J Manag Care Pharm. 2009;15:335-43.
PMid:19422273

 

8. Jakubowski JA, Riesmeyer JS, Close SL, Leishman AG, Erlinge D. Triton and beyond: new insights into the profile of prasugrel. Cardiovasc Ther. 2012;30:174-82.
http://dx.doi.org/10.1111/j.1755-5922.2011.00263.x
PMid:21883999 PMCid:PMC3440581

 

9. Becker RC, Bassand JP, Budaj A, Wojdyla DM, James SK, Cornel JH, et al. Bleeding complica-tions with the P2Y12 receptor antagonist clopidogrel and ticagrelor in Platelet inhibition and patient outcomes (PLATO) trial. Eur Heart J. 2011;32:2933-44.
http://dx.doi.org/10.1093/eurheartj/ehr422
PMid:22090660

 

10. Quinlan DJ, Eikelboom JW, Goodman SG, Welsh RC, Fitchett DH, Théroux P, et al. Implica-tions of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes. Eur Heart J. 2011;32:2256-65.
http://dx.doi.org/10.1093/eurheartj/ehr143
PMid:21624900

 

11. Hong CH, Nape-as JJ, Brennan MT, Furney SL, Lockhart PB. Frequency of bleeding following invasive dental procedures in patients on low-molecular-weight heparin ther-apy. J Oral Maxillofac Surg. 2010;68:975-9.
http://dx.doi.org/10.1016/j.joms.2009.09.054
PMid:20144498

 

12. Jiménez Y, Poveda R, Gavaldá C, Margaix M, Sarrión G. An update on the management of anticoagulated patients programmed for dental extractions and surgery. Med Oral Patol Oral Cir Bucal. 2008;13:E176-9.
PMid:18305438

 

13. Vicente Barrero M, Knezevic M, Tapia Martín M, Viejo Llorente A, Orengo Valverde JC, García Jiménez F, et al. Oral surgery in patients undergoing oral anticoagulant therapy. Med Oral. 2002;7:63-70.
PMid:11788810

 

14. Prasad V, Kaplan RM, Passman RS. New frontiers for stroke prevention in atrial fibrillation. Cerebrovasc Dis. 2012;33:199-208.
http://dx.doi.org/10.1159/000334979
PMid:22261539

 

15. Zapata-Wainberg G, Ximénez-Carrillo Rico A, Vivancos-Mora J. [Clinical management of the new anticoagulants]. Neurologia. 2012;27 Suppl 1:33-8.
http://dx.doi.org/10.1016/S0213-4853(12)70006-3

 

16. Healey JS, Eikelboom J, Douketis J, Wallentin L, Oldgren J, Yang S, et al. Periprocedural bleeding and thromboembolic events with Dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation. 2012;126:343-8
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.090464
PMid:22700854

 

17. Harenberg J, Marx S, Krejczy M, Wehling M. New anticoagulants promising and failed devel-opments. Br J Pharmacol. 2012;165:363-72.
http://dx.doi.org/10.1111/j.1476-5381.2011.01578.x
PMid:21740405 PMCid:PMC3268190

 

18. Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother. 2012;46:e21.
http://dx.doi.org/10.1345/aph.1R081
PMid:22872748

 

19. Schulman S, Crowther MA. How I treat anticoagulants in 2012: new and old anticoagulants, and when and how to switch. Blood. 2012;119:3016-23.
http://dx.doi.org/10.1182/blood-2011-10-378950
PMid:22302737

 

20. Norgard NB, Dinicolantonio JJ, Topping TJ, Wee B. Novel anticoagulants in atrial fibrillation stroke prevention. Ther Adv Chronic Dis. 2012;3:123-36.
http://dx.doi.org/10.1177/2040622312438934
PMid:23251773 PMCid:PMC3513906

 

21. Koskinas KC, Lillis T, Tsirlis A, Katsiki N, Giannoglou GD, Ziakas AG. Dental manage-ment of antiplatelet-receiving patients: is uninterrupted antiplatelet therapy safe? Angiology. 2012;63:245-7.
http://dx.doi.org/10.1177/0003319711425921
PMid:22500009

 

22. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-50S.

 

23. Pereira CM, Gasparetto PF, Carneiro DS, Corrêa ME, Souza CA. Tooth extraction in patients on oral anticoagulants: prospective study conducted in 108 brazilian patients. ISRN Dent. 2011;2011:203619.

 

24. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective pro-cedure or surgery. Blood. 2012;120:2954-62.
http://dx.doi.org/10.1182/blood-2012-06-415943
PMid:22932800

 

25. Rodríguez-Cabrera MA, Barona-Dorado C, Leco-Berrocal I, Gómez-Moreno G, Martínez-González JM. Extraction without eliminating anticoagulant treatment: a literatura review. Med Oral Patol Oral Cir Bucal. 2011;16:e800-4.
http://dx.doi.org/10.4317/medoral.17065
PMid:21196857

 

26. Tuvignon N, Liguory C, Ponchon T, Meduri B, Fritsch J, Sahel J, et al. Endoscopy and anti-platelet agents. European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2011;43:445-61.
http://dx.doi.org/10.1055/s-0030-1256317
PMid:21547880

 

27. Lillis T, Ziakas A, Koskinas K, Tsirlis A, Giannoglou G. Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol. 2011;108:964-7.
http://dx.doi.org/10.1016/j.amjcard.2011.05.029
PMid:21784392

 

28. Cardona-Tortajada F, Sainz-Gómez E, Figuerido-Garmendia J, de Robles-Adsuar AL, Morte-Casabó A, Giner-Mu-oz F, et al. Dental extractions in patients on antiplatelet therapy. A study con-ducted by the Oral Health Department of the Navarre Health Service (Spain). Med Oral Patol Oral Cir Bucal. 2009;14:e588-92.
http://dx.doi.org/10.4317/medoral.14.e588
PMid:19680200

 

29. Park MW, Her SH, Kwon JB, Lee JB, Choi MS, Cho JS, et al. Safety of dental extractions in coronary drug-eluting stenting patients without stopping multiple antiplatelet agents. Clin Cardiol. 2012;35:225-30.
http://dx.doi.org/10.1002/clc.21960
PMid:22278596

 

30. Ca-igral A, Silvestre FJ, Ca-igral G, Alós M, Garcia-Herraiz A, Plaza A. Evaluation of bleeding risk and measurement methods in dental patients. Med Oral Patol Oral Cir Bucal. 2010;15:e863-8.
http://dx.doi.org/10.4317/medoral.15.e863

 

31. García DA, Granger CB. Anticoagulation, novel agents and procedures: can we pardon the interruption?. Circulation. 2012;126:255-7.
http://dx.doi.org/10.1161/CIRCULATIONAHA.112.115188
PMid:22700855

 

32. Firriolo FJ, Hupp WS. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:431-41.
http://dx.doi.org/10.1016/j.oooo.2011.10.005
PMid:22668425

 

33. Scully C, Wolff A. Oral surgery in patients on anticoagulant therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:57-64.
http://dx.doi.org/10.1067/moe.2002.123828